These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1010 related items for PubMed ID: 16598757

  • 1. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S, Sugio K, Uramoto H, Oyama T, Hanagiri T, Morita M, Yasumoto K.
    Cancer; 2006 May 15; 106(10):2190-9. PubMed ID: 16598757
    [Abstract] [Full Text] [Related]

  • 2. Hypermethylation of FHIT as a prognostic marker in nonsmall cell lung carcinoma.
    Maruyama R, Sugio K, Yoshino I, Maehara Y, Gazdar AF.
    Cancer; 2004 Apr 01; 100(7):1472-7. PubMed ID: 15042681
    [Abstract] [Full Text] [Related]

  • 3. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
    Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH.
    Carcinogenesis; 2004 Nov 01; 25(11):2165-71. PubMed ID: 15231689
    [Abstract] [Full Text] [Related]

  • 4. Exclusive mutation in epidermal growth factor receptor gene, HER-2, and KRAS, and synchronous methylation of nonsmall cell lung cancer.
    Suzuki M, Shigematsu H, Iizasa T, Hiroshima K, Nakatani Y, Minna JD, Gazdar AF, Fujisawa T.
    Cancer; 2006 May 15; 106(10):2200-7. PubMed ID: 16598760
    [Abstract] [Full Text] [Related]

  • 5. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
    Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH.
    J Clin Oncol; 2004 Jun 15; 22(12):2363-70. PubMed ID: 15197197
    [Abstract] [Full Text] [Related]

  • 6. Cohypermethylation of p16 and FHIT promoters as a prognostic factor of recurrence in surgically resected stage I non-small cell lung cancer.
    Kim JS, Kim JW, Han J, Shim YM, Park J, Kim DH.
    Cancer Res; 2006 Apr 15; 66(8):4049-54. PubMed ID: 16618724
    [Abstract] [Full Text] [Related]

  • 7. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N, Tamura G, Oizumi H, Kanauchi N, Endoh M, Sadahiro M, Motoyama T.
    Lung Cancer; 2007 Oct 15; 58(1):131-8. PubMed ID: 17606310
    [Abstract] [Full Text] [Related]

  • 8. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, Wang YC.
    Cancer; 2007 Nov 01; 110(9):2019-26. PubMed ID: 17876837
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M, Merk J, Stoehr R, Schaeper F, Gaumann A, Wiebe K, Hartmann A, Hofstaedter F, Dietmaier W.
    Hum Pathol; 2008 Jan 01; 39(1):126-36. PubMed ID: 17949785
    [Abstract] [Full Text] [Related]

  • 10. Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma.
    Kim JS, Han J, Shim YM, Park J, Kim DH.
    Cancer; 2005 Nov 01; 104(9):1825-33. PubMed ID: 16177988
    [Abstract] [Full Text] [Related]

  • 11. Aberrant methylation of E-cadherin and H-cadherin genes in nonsmall cell lung cancer and its relation to clinicopathologic features.
    Kim DS, Kim MJ, Lee JY, Kim YZ, Kim EJ, Park JY.
    Cancer; 2007 Dec 15; 110(12):2785-92. PubMed ID: 17960794
    [Abstract] [Full Text] [Related]

  • 12. Reduced acetylated histone H4 is associated with promoter methylation of the fragile histidine triad gene in resected esophageal squamous cell carcinoma.
    Tzao C, Sun GH, Tung HJ, Hsu HS, Hsu WH, Wang YC, Cheng YL, Lee SC.
    Ann Thorac Surg; 2006 Aug 15; 82(2):396-401; discussion 401. PubMed ID: 16863736
    [Abstract] [Full Text] [Related]

  • 13. p16(INK4a) and histology-specific methylation of CpG islands by exposure to tobacco smoke in non-small cell lung cancer.
    Kim DH, Nelson HH, Wiencke JK, Zheng S, Christiani DC, Wain JC, Mark EJ, Kelsey KT.
    Cancer Res; 2001 Apr 15; 61(8):3419-24. PubMed ID: 11309302
    [Abstract] [Full Text] [Related]

  • 14. 5'CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer.
    Tzao C, Tsai HY, Chen JT, Chen CY, Wang YC.
    Eur J Cancer; 2004 Sep 15; 40(14):2175-83. PubMed ID: 15341994
    [Abstract] [Full Text] [Related]

  • 15. Clinicopathological significance of aberrant methylation of RARbeta2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer.
    Tomizawa Y, Iijima H, Nomoto T, Iwasaki Y, Otani Y, Tsuchiya S, Saito R, Dobashi K, Nakajima T, Mori M.
    Lung Cancer; 2004 Dec 15; 46(3):305-12. PubMed ID: 15541815
    [Abstract] [Full Text] [Related]

  • 16. Hypermethylation of E-cadherin gene is frequent and independent of p16INK4A methylation in non-small cell lung cancer: potential prognostic implication.
    Shimamoto T, Ohyashiki JH, Hirano T, Kato H, Ohyashiki K.
    Oncol Rep; 2004 Aug 15; 12(2):389-95. PubMed ID: 15254707
    [Abstract] [Full Text] [Related]

  • 17. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer.
    Rohr UP, Rehfeld N, Geddert H, Pflugfelder L, Bruns I, Neukirch J, Rohrbeck A, Grote HJ, Steidl U, Fenk R, Opalka B, Gabbert HE, Kronenwett R, Haas R.
    Clin Cancer Res; 2005 Jan 01; 11(1):180-5. PubMed ID: 15671544
    [Abstract] [Full Text] [Related]

  • 18. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer.
    Hsu HS, Wang YC, Tseng RC, Chang JW, Chen JT, Shih CM, Chen CY, Wang YC.
    Clin Cancer Res; 2004 Jul 15; 10(14):4734-41. PubMed ID: 15269146
    [Abstract] [Full Text] [Related]

  • 19. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT.
    Oncogene; 2002 Jun 20; 21(27):4231-6. PubMed ID: 12082610
    [Abstract] [Full Text] [Related]

  • 20. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H, Geeraerts H, Verbeken E, Nuyts S.
    Oncol Rep; 2009 Feb 20; 21(2):507-13. PubMed ID: 19148529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.